The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
Open accessAbstract
Neuroinflammation is a conspicuous feature of Alzheimer disease (AD) pathology and is thought to contribute to the ultimate neurodegeneration that ensues. IL-1 beta has emerged as a prime candidate underlying this response. Here we describe a transgenic mouse model of sustained IL-1 beta overexpression that was capable of driving robust neuroinflammation lasting months after transgene activation. This response was characterized by astrocytic and microglial activation in addition to induction of proinflammatory cytokines. Surprisingly, when triggered in the hippocampus of the APPswe/PS1dE9 mouse model of AD, 4 weeks of IL-1 beta overexpression led to a reduction in amyloid pathology. Congophilic plaque area fraction and frequency as well as insoluble amyloid beta 40 (A beta 40) and A beta 42 decreased significantly. These results demonstrate a possible adaptive role for IL-1 beta-driven neuroinflammation in AD and may help explain recent failures of antiinflammatory therapeutics for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“previous studies demonstrated that IL1 overexpression enhances A clearance.9,53”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is consistent with our previously published data showing that IL-1β does not influence Aβ production [4, 6, 7, 28].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For amyloid pathology, there is data that activated micro/astroglia enhances Aβ phagocytosis [60, 62, 71]”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent studies demonstrated that overexpression of IL1, an inflammatory cytokine leads to reduced A pathology in mouse models of AD. 9,53”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Various genetically modified mouse models have convincingly demonstrated the role for other chemokines/cytokine pathways in altering the accumulation of mononuclear phagocytes (monocytes, macrophages, and microglia) and A pathology, including CCR2 59 and IL1.9”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“numerous other studies have suggested that altering the proliferation, 58 signaling, 8,9,11 and migration 7,59 of microglia directly impact development of A pathology.”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“As previously described [28], APP/PS1 mice transduced with rAAV2-IL-1β showed significant reductions in hippocampal amyloid plaques compared to mice treated with rAAV2-Phe, as determined by immunohistochemical (IHC) analysis using both 6E10 staining and MX04 (Fig. 1b)”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“Hippocampal expression of IL-1β was shown to robustly reduce plaques in the APP/PS1 model and 3xTg-AD model but worsened tauopathy in the 3xTg-AD model [62, 63].”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [62]
In the citing paper
“In turn, increased cytokines, such as interleukin-1, can influence Aβ uptake (Mrak and Griffin, 2000; Shaftel et al., 2007).”
From LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease (2019) · cites this paper as Shaftel et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W. K., Teter, B., Tran, T., Ubeda, O. J., Ashe, K. H., Frautschy, S. A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 876
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., & Borchelt, D. R. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00067-3 · Cited by 746
Cited by
Sorted by citations
Items 201–300 of 427
Expression of Tau40 Induces Activation of Cultured Rat Microglial Cells
Wang, L., Jiang, Q., Chu, J., Lin, L., Li, X.-G., Chai, G.-S., Wang, Q., Wang, J.-Z., & Tian, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076057 · Cited by 47
Degaspari, S., Tzanno-Martins, C., Fujihara, C. K., Zatz, R., Branco-Martins, J. P., Viel, T. A., Buck, H. S., Orellana, A. M., Böhmer, A. E., Lima, L. D. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125271 · Cited by 47
Jansen, D., Zerbi, V., Arnoldussen, I. A. C., Wiesmann, M., Rijpma, A., Fang, X. T., Dederen, P. J. W. C., Mutsaers, M. P. C., Broersen, L. M., Lütjohann, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075393 · Cited by 47
Tian, L., Hui, C. W., Bisht, K., Tan, Y., Sharma, K. P., Chen, S., Zhang, X., & Tremblay, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.007 · Cited by 52
Stress and Alzheimer’s disease: A senescence link?
Lyons, C. E., & Bartolomucci, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.010 · Cited by 49
Niranjan, R., Nath, C., & Shukla, R. (2012) · Free Radical Research · doi:10.3109/10715762.2012.697626 · Cited by 46
A Changing Perspective on the Role of Neuroinflammation in Alzheimer's Disease
Wilcock, D. M. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/495243 · Cited by 48
Spinal interleukin‐1β in a mouse model of arthritis and joint pain
Fiorentino, P. M., Tallents, R. H., Miller, J. H., Brouxhon, S. M., O’Banion, M. K., Puzas, J. E., & Kyrkanides, S. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23866 · Cited by 46
Self-citationBales, K. R. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.666234 · Cited by 46
Hoffman, W. H., Artlett, C. M., Zhang, W., Kreipke, C. W., Passmore, G. G., Rafols, J. A., & Sima, A. A. F. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.041 · Cited by 46
Heparan Sulfate Proteoglycans as Relays of Neuroinflammation
O’Callaghan, P., Zhang, X., & Li, J. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417742147 · Cited by 47
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
Stožická, Z., Žilka, N., Novák, P., Kováčech, B., Bugos, O., & Novák, M. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-64 · Cited by 46
IFN‐γ promotes τ phosphorylation without affecting mature tangles
Li, A., Ceballos‐Diaz, C., DiNunno, N., Levites, Y., Cruz, P. E., Lewis, J., Golde, T. E., & Chakrabarty, P. (2015) · The FASEB Journal · doi:10.1096/fj.15-275834 · Cited by 43
Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease
Kamat, P. K., Swarnkar, S., Rai, S., Kumar, V., & Tyagi, N. (2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.243 · Cited by 42
Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease
Lee, J., Cho, E., Seo, J.-W., Hwang, J. J., & Koh, J. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182417387 · Cited by 42
Zhang, Y., Chen, C., Jiang, Y., Wang, S., Wu, X., & Wang, K. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0387-7 · Cited by 42
Fresh evidence for major brain gangliosides as a target for the treatment of Alzheimer's disease
Dukhinova, M., Veremeyko, T., Yung, A. W. Y., Kuznetsova, I. S., Lau, T. Y. B., Kopeikina, E., Chan, A. M.-L., & Ponomarev, E. D. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.020 · Cited by 41
Peterson, T. S., Thebeau, C. N., Ajit, D., Camden, J. M., Woods, L. T., Wood, W. G., Petris, M. J., Sun, G. Y., Erb, L., & Weisman, G. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12252 · Cited by 41
Hoshino, T., Namba, T., Takehara, M., Murao, N., Matsushima, T., Sugimoto, Y., Narumiya, S., Suzuki, T., & Mizushima, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07567.x · Cited by 40
Yousif, N. M., de Oliveira, A. C. P., Brioschi, S., Hüell, M., Biber, K. P. H., & Fiebich, B. L. (2017) · Glia · doi:10.1002/glia.23276 · Cited by 40
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Pons, V., & Rivest, S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000400 · Cited by 41
Cross-species evidence for the role of interleukin-33 in depression risk.
Kudinova, A. Y., Deak, T., Hueston, C. M., McGeary, J. E., Knopik, V. S., Palmer, R. H. C., & Gibb, B. E. (2016) · Journal of Abnormal Psychology · doi:10.1037/abn0000158 · Cited by 38
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2844-6 · Cited by 39
Heme and hemoglobin suppress amyloid β–mediated inflammatory activation of mouse astrocytes
Sankar, S. B., Donegan, R. K., Shah, K. J., Reddi, A. R., & Wood, L. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001050 · Cited by 41
Xing, Z., Zuo, Z., Hu, D., Zheng, X., Wang, X., Yuan, L., Zhou, L., Qi, F., & Yao, Z. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.015 · Cited by 38
Oyeleke, M. B., & Owoyele, B. V. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.114997 · Cited by 38
Staging anti-inflammatory therapy in Alzheimer’s disease
Lichtenstein, M. P. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00142 · Cited by 39
Choi, J.-H., Lee, E.-B., Jang, H., Cha, Y., Park, Y., & Lee, S. H. (2021) · Nutrients · doi:10.3390/nu13082890 · Cited by 38
Potential Immunotargets for Alzheimer's Disease Treatment Strategies
Fernández, P. L., Britton, G. B., & Rao, K. S. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121222 · Cited by 38
Shahrokhi, V. M., Ravari, A., Mirzaei, T., Zare‐Bidaki, M., Asadikaram, G., & Arababadi, M. K. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1504300 · Cited by 37
Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain
Weekman, E. M., Woolums, A. E., Sudduth, T. L., & Wilcock, D. M. (2017) · ASN NEURO · doi:10.1177/1759091417742296 · Cited by 36
Zhang, H., Wang, P., Yu, H., Yu, K., Cao, Z., Xu, F., Yang, X., Song, M., & Li, Y. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.03.162 · Cited by 36
Rivera-Escalera, F., Matousek, S. B., Ghosh, S., Olschowka, J. A., & O’Banion, M. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.018 · Cited by 34
Self-citationDorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation
Howerton, A. R., Roland, A. V., & Bale, T. L. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0118-14.2014 · Cited by 33
Boraschi, D., Italiani, P., Migliorini, P., & Bossù, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128190 · Cited by 38
Kumar, A., Sharma, S., Prashar, A., & Deshmukh, R. R. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0414-4 · Cited by 33
Immunology meets neuroscience – Opportunities for immune intervention in neurodegenerative diseases
Lynch, M. A., & Mills, K. H. G. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.013 · Cited by 34
Immunotherapy as treatment for Alzheimer’s disease
Hawkes, C. A., & McLaurin, J. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1535 · Cited by 33
Solomon, U., & Eduviere, A. T. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.04.002 · Cited by 32
Clements, A. E. B., & Murphy, W. L. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.04.051 · Cited by 32
Herr, D., Jew, K., Wong, C., Kennell, A., Gelein, R. M., Chalupa, D., Raab, A., Oberdörster, G., Olschowka, J. A., O’Banion, M. K., et al. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.03.010 · Cited by 34
Self-citationLuo, Q., Schnöder, L., Hao, W., Litzenburger, K., Decker, Y., Tomic, I., Menger, M. D., Fassbender, K. C., & Fassbender, K. C. (2022) · Aging Cell · doi:10.1111/acel.13679 · Cited by 35
Teixeira, A. L., Reis, H. J., Coelho, F. M., Carneiro, D. S., Teixeira, M. M., Vieira, L. B., Mukhamedyarov, M. A., Zefirov, A. L., Janka, Z., & Palotás, A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.019 · Cited by 32
Role of CCR2 in immunobiology and neurobiology
Yamasaki, R., Liu, L., Lin, J., & Ransohoff, R. M. (2011) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2011.00024.x · Cited by 31
Hastings, A. K., Hastings, K., Uraki, R., Hwang, J., Gaitsch, H., Dhaliwal, K., Williamson, E., & Fikrig, E. (2019) · iScience · doi:10.1016/j.isci.2019.03.003 · Cited by 33
Alemán-Villa, K. M., Armienta-Rojas, D. A., Camberos-Barraza, J., Rábago-Monzón, Á. R., Camacho-Zamora, A., Osuna‐Ramos, J. F., Magaña‐Gómez, J. A., Guadrón‐Llanos, A. M., Calderón-Zamora, L., Norzagaray-Valenzuela, C. D., et al. (2025) · NeuroImmunoModulation · doi:10.1159/000548021 · Cited by 34
Amyloid-beta impairs TOM1-mediated IL-1R1 signaling
Martini, A. C., Gómez-Arboledas, Á., Forner, S., Rodríguez‐Ortiz, C. J., McQuade, A., Danhash, E., Phan, J., Javonillo, D. I., Ha, J. V., Tram, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914088116 · Cited by 31
Łabuzek, K., Liber, S., Gabryel, B., & Okopień, B. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.10.006 · Cited by 30
Gardiner, J. C., Barton, D., Vanslambrouck, J. M., Braet, F., Hall, D. H., Marc, J., & Overall, R. L. (2007) · The Neuroscientist · doi:10.1177/1073858407312382 · Cited by 30
Ashok, A., Keener, R., Rubenstein, M., Stookey, S., Bajpai, S., Hicks, J. L., Alme, A., Drake, C. G., Zheng, Q., Trabzonlu, L., et al. (2019) · The Prostate · doi:10.1002/pros.23784 · Cited by 30
Mondal, A., Saha, P., Bose, D., Chatterjee, S., Seth, R. K., Xiao, S., Porter, D. E., Brooks, B. W., Scott, G., Nagarkatti, M., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152901 · Cited by 29
Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model
Lloyd, G. M., Dhillon, J.-K. S., Gorion, K.-M. M., Riffe, C. J., Fromholt, S., Xia, Y., Giasson, B. I., & Borchelt, D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00486-9 · Cited by 29
Chen, Y., Vaine, M., Wallace, A., Han, D. G., Wan, S., Seaman, M. S., Montefiori, D. C., Wang, S., & Lu, S. (2013) · Journal of Virology · doi:10.1128/jvi.00837-13 · Cited by 28
Pilat, D., Paumier, J.-M., García-González, L., Louis, L., Stephan, D., Manrique, C., Khrestchatisky, M., Di Pasquale, E., Baranger, K., & Rivera, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02407-z · Cited by 28
The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice
Puig, K. L., Kulas, J. A., Franklin, W. F., Rakoczy, S. G., Taglialatela, G., Brown‐Borg, H. M., & Combs, C. K. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.021 · Cited by 31
Ridolfi, E., Barone, C., Scarpini, E. A., & Galimberti, D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/939786 · Cited by 28
Pawley, L. C., Hueston, C. M., O’Leary, J. D., Kozareva, D. A., Cryan, J. F., O’Leary, O. F., & Nolan, Y. M. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.10.007 · Cited by 28
Wu, L., Kalish, B. T., Finander, B., Cao, T., Jin, G., Yahya, T., Levy, E. S., Kukreja, B., LaRovere, E. S., Chung, J. Y., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0682-21.2021 · Cited by 28
Panayiotou, E., Fella, E., Andreou, S., Papacharalambous, R., Gerasimou, P., Costeas, P., Angeli, S., Kousiappa, I., Papacostas, S., & Kyriakides, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225417 · Cited by 26
Physical exercise shapes the mouse brain epigenome
Urdinguio, R. G., Tejedor, J. R., Fernández‐Sanjurjo, M., Pérez, R. F., Peñarroya, A., Ferrero, C., Codina‐Martínez, H., Díez‐Planelles, C., Pinto-Hernández, P., Castilla‐Silgado, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101398 · Cited by 28
Doroszkiewicz, J., Winkel, I., & Mroczko, B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1579511 · Cited by 26
Small Molecule Inhibition of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4)
Genung, N. E., & Guckian, K. M. (2017) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2016.11.004 · Cited by 25
Hein, A. M., Zarcone, T. J., Parfitt, D. B., Matousek, S. B., Carbonari, D. M., Olschowka, J. A., & O’Banion, M. K. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9294-3 · Cited by 24
Self-citationRevuelta, M., Urrutia, J., Villarroel, Á., & Casis, Ó. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.868842 · Cited by 24
The role of Alu-derived RNAs in Alzheimer’s and other neurodegenerative conditions
Polesskaya, O., Kananykhina, E. Y., Roy‐Engel, A. M., Nazarenko, O., Kulemzina, I. A., Baranova, A. V., Vassetzky, Y. S., & Myakishev-Rempel, M. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.03.008 · Cited by 23
Huang, C., Hsu, S., Tsai, S., Chen, N.-C., Liu, M., Lee, C., Huang, S., Chang, W.-N., Chang, Y., Tsai, W., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0791-z · Cited by 23
Khan, M. I., Khan, M. Z., Shin, J. H., Shin, T. S., Lee, Y. B., Kim, M. Y., & Kim, J. D. (2022) · Molecules · doi:10.3390/molecules27072079 · Cited by 24
Han, S. H., Kim, J. S., Woo, J. H., Jeong, S. J., Shin, J., Ahn, Y. S., & Kim, J. M. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.1.112 · Cited by 22
Neuroprotective Effects and Mechanism of β‐Asarone against Aβ1–42‐Induced Injury in Astrocytes
Yang, Y., Xuan, L., Chen, H., Dai, S., Ji, L., Bao, Y., & Li, C. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8516518 · Cited by 23
Wtpsk, S., Oikari, L. E., Bharadwaj, P., Jayasena, V., Martins, R. N., & Fernando, W. M. A. D. B. (2025) · Nutrients · doi:10.3390/nu17142286 · Cited by 23
Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer’s Disease
Weber, G. E., Khrestian, M., Tuason, E. D., Shao, Y. Y., Pillai, J. A., Rao, S. M., Feng, H., Zhou, Y., Cheng, F., DeSilva, T. M., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100771 · Cited by 22
A beneficial role for IL-1β in Alzheimer disease?
Lemere, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32356 · Cited by 22
Brain interleukins and Alzheimer’s disease
Abdelhamed, H. G., Hassan, A. A., Sakraan, A., Al-Deeb, R. T., Mousa, D. M., Ezz, H. S. A., Noor, N. A., Khadrawy, Y. A., & Radwan, N. M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01538-5 · Cited by 20
Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 20
Luo, X., Liu, Y., Chen, X., & Li, S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.11.015 · Cited by 20
Niranjan, R., Nath, C., & Shukla, R. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9684-3 · Cited by 20
Li, Y., Xing, Y., Shen, Y., Zhao, J., Yue, R., Liu, F., He, W., Wang, R., Shan, L., & Zhang, W. (2016) · Aging · doi:10.18632/aging.100913 · Cited by 20
Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer’s Disease
Dionisio-Santos, D. A., Behrouzi, A., Olschowka, J. A., & O’Banion, M. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00441 · Cited by 20
Self-citationMutations modifying sporadic Alzheimer’s disease age of onset
Vélez, J. I., Lopera, F., Patel, H. R., Johar, A. S., Cai, Y., Rivera, D., Tobón, C., Villegas, A., Sepulveda‐Falla, D., Lehmann, S. G., et al. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32493 · Cited by 19
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
Busch, L., Eggert, S., Endres, K., & Bufe, B. (2022) · Cells · doi:10.3390/cells11213421 · Cited by 20
Involvement of inflammasomes in the pathogenesis of Alzheimer's disease
Beder, N., Belkhelfa, M., & Leklou, H. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283677 · Cited by 20
CX3C-chemokine receptor 1 modulates cognitive dysfunction induced by sleep deprivation
Xin, J., Wang, C., Cheng, X., Xie, C., Zhang, Q., Ke, Y., Huang, X., Chen, X., & Pan, X. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001769 · Cited by 20
Transport of cargo from periphery to brain by circulating monocytes
Cintron, A. F., Dalal, N. V., Dooyema, J. M., Betarbet, R. S., & Walker, L. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.047 · Cited by 19
Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
Ibanez, K. R., McFarland, K. N., Phillips, J., Allen, M., Lessard, C. B., Zobel, L., De La Cruz, E. G., Shah, S., Vo, Q., Wang, X., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01044-1 · Cited by 18
Ciccone, L., Nencetti, S., Rossello, A., & Orlandini, E. (2023) · Pharmaceuticals · doi:10.3390/ph16071036 · Cited by 18
Yadav, V., Mythri, C., & Kumarasamy, M. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100048 · Cited by 22
Chowdhury, T., Allen, M. F., Thorn, T. L., He, Y., & Hewett, S. J. (2018) · Antioxidants · doi:10.3390/antiox7080100 · Cited by 18
Interferons: A molecular switch between damage and repair in ageing and Alzheimer’s disease
Gorlé, N., & Vandenbroucke, R. E. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111148 · Cited by 18
Side-Chain Immune Oxysterols Induce Neuroinflammation by Activating Microglia
Son, Y., Yeo, I.-J., Hong, J. T., Eo, S. K., Lee, D., & Kim, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015288 · Cited by 16
The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer’s disease
Salminen, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02504-x · Cited by 16
Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
Huang, Y., Hong, X., Shen, J. X., Geng, L.-J., Pan, Y.-H., Ling, W., & Zhao, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02980 · Cited by 16
Aparicio, N., Grande, M. T., Esteban, S. R. D. M., López, A., Ruiz‐Pérez, G., Amores, M., Vázquez, C., Martínez-Relimpio, A. M., Pazos, M. R., Cravatt, B. F., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.009 · Cited by 16
Inflammatory Cytokine IL-1β Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing
Hsu, H.-W., Rodríguez‐Ortiz, C. J., Zumkehr, J., & Kitazawa, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.021 · Cited by 16
Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration
Zhang, S., Meng, R., Jiang, M., Qing, H., & Ni, J. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230203103910 · Cited by 16
Bettcher, B. M., de Oliveira, F. F., Willette, A. A., Michalowska, M. M., Machado, L. S., Rajbanshi, B., Borelli, W. V., Tansey, M. G., da Rocha, A. S., Suryadevara, V., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03432-4 · Cited by 16
François, A., Julian, A., Ragot, S., Dugast, E., Blanchard, L., Brishoual, S., Chassaing, D., Page, G., & Paccalin, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138326 · Cited by 16
Emerging trends in IRAK-4 kinase research
Yadav, H. K., & Shirumalla, R. K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08438-w · Cited by 15
Pro-Inflammatory Cytokine Genes Influence the Clinical Features of Frontotemporal Lobar Degeneration
Rainero, I., Rubino, E., Cappa, G., Rota, E., Valfrè, W., Ferrero, P., Fenoglio, P., Baci, D., D’Amico, G., Vaula, G., et al. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000225962 · Cited by 15
Neuroinflammation, Type 2 Diabetes, and Dementia
Wong, C. H. Y., Wanrooy, B. J., & Bruce, D. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00010-x · Cited by 14
Metadata
- Authors
- Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- O’Banion, M. Kerry
- Venue
- Journal of Clinical Investigation
- Published
- 2007-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 1595-1604
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1878531
- OpenAlex
- W2105385589
- Cited by
- 433
- References
- 46
- Citations by year
- 2026: 8 · 2025: 25 · 2024: 16 · 2023: 18 · 2022: 34 · 2021: 22 · 2020: 20 · 2019: 26 · 2018: 23 · 2017: 20 · 2016: 18 · 2015: 24 · 2014: 32 · 2013: 26 · 2012: 35
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Rochester
- National Institutes of Health (14642)
- Medical Center, University of Rochester
- National Institute of General Medical Sciences (GM 07356, T32GM007356)
- National Institute of Neurological Disorders and Stroke (NS048522, R29NS033553, NS 33553, R21NS048522, R01NS033553)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- IL-1β, neuroinflammation, Alzheimer's disease, amyloid plaques, hippocampus, astrocyte activation, microglial activation, inflammatory cytokines, APPswe/PS1dE9 transgenic mice, amyloid-beta
- MeSH terms
- Alzheimer Disease, Animals, Base Sequence, Disease Models, Animal, Hippocampus, Humans, Inflammation, Mice, Transgenic, Nerve Degeneration, Recombinant Proteins, Gene Expression, Amyloid beta-Protein Precursor, DNA Primers, Mice, Interleukin-1beta, Presenilin-1, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
